RESIST AMR Consortium
Proud to announce the formation of the RESIST AMR Consortium, bringing together Africlinix Solutions Ltd (UK), the University of Wolverhampton (UK), and HIGHER INSTITUTE FOR SCIENTIFIC AND MEDICAL RESEARCH Cameroon to advance research, surveillance, innovation, and stewardship against antimicrobial resistance across Africa. We are especially honored to collaborate with Professor Joseph Kamgno of HIGHER INSTITUTE FOR SCIENTIFIC AND MEDICAL RESEARCH Cameroon, whose internationally recognized leadership in infectious diseases and global health research brings tremendous strength to this initiative as we prepare our proposal for the NIHR Tackling Bacterial and Fungal Antimicrobial Resistance in Sub-Saharan Africa and South Asia Call.
hashtag#AMR hashtag#AntimicrobialResistance hashtag#NIHR hashtag#GlobalHealth hashtag#ResearchCollaboration hashtag#AfricaResearch hashtag#OneHealth hashtag#ClinicalResearch hashtag#CapacityBuilding hashtag#RESISTAMR
PREVENT AMR Sepsis Consortium
Excited to announce the formation of the PREVENT AMR Sepsis Consortium, bringing together Africlinix Solutions Ltd, the University of Wolverhampton, and Institut Pasteur de Côte d'Ivoire to tackle antimicrobial resistance and sepsis across Africa through research, surveillance, innovation, and capacity strengthening. We are particularly privileged to work alongside Professor André Offianan, whose distinguished leadership and expertise in infectious diseases and public health research will be invaluable as we prepare our application to the NIHR Tackling Bacterial and Fungal Antimicrobial Resistance in Sub-Saharan Africa and South Asia Call.
#AMR #Sepsis #NIHR #GlobalHealth #AfricaResearch #InstitutPasteur #UniversityOfWolverhampton #Africlinix #ResearchPartnership #OneHealth
OPT-TPT Africa Consortium
Africlinix Solutions is pleased to announce its role as the coordinating partner for the OPT-TPT Africa Consortium, a multi-country initiative focused on optimizing Tuberculosis Preventive Therapy (TPT) among People Living with HIV (PLHIV).
The consortium brings together leading institutions from across Africa and the United Kingdom, including the UZ-CTRC, Zimbabwe, Botswana Harvard Health Partnership Botswana, Ifakara Health Institute (IHI) Tanzania, Kilimanjaro Clinical Research Institute (KCRI) Tanzania and National Institute for Medical Research (NIMR) Mbeya Medical Research Centre Tanzania,
The OPT-TPT Africa Trial will evaluate WHO-recommended TPT regimens to generate evidence on treatment completion, adherence, safety, cost-effectiveness, and long-term TB prevention outcomes in real-world settings.
As coordinating partner, Africlinix Solutions is supporting consortium coordination, research development, stakeholder engagement, and operational planning to help deliver impactful African-led research that informs policy and strengthens TB prevention programmes across the continent.
Together, we are advancing collaborative science to accelerate progress towards ending TB in Africa.
Tagline
IOI Early Career Researcher Conference 2026 today at Saïd Business School, University of Oxford.
Excited to have attended the 📍 IOI Early Career Researcher Conference 2026 today at Saïd Business School, University of Oxford.
A fantastic gathering of emerging researchers, innovators, and thought leaders sharing insights on advancing global research impact. Conversations around collaboration, translational science, and innovation ecosystems were particularly inspiring.
We were also proud to present Africlinix, showcasing our mission to bridge UK biotech, pharma, and universities in the discovery space with expert clinical trialists from Africa—unlocking high-impact, globally relevant research partnerships.
Grateful for the opportunity to engage, learn, and connect with such a dynamic community shaping the future of research.
🔗 Details: https://lnkd.in/eXdiRqAA
Africlinix will be attending the IOI Early Career Researcher Conference 2026
Friday, 20 March 2026
Said Business School, Oxford
IOI's annual flagship Early Career Researcher Conference brings together researchers, clinicians, industry experts, and postgraduate students working across the field of antimicrobial resistance (AMR). The event provides a forum to share new findings, exchange ideas, and strengthen interdisciplinary approaches to tackle the global threat of AMR.
Attracting more than 200 attendees each year, the conference features keynote speakers, invited talks, and flash talks and poster presentations from early career researchers. Sessions span drug discovery, microbiology, digital genomics, social science, clinical practice, and other fields driving innovation in antimicrobial resistance research.